Cardinal Point Capital Management ULC
Source: SEC Form 13F · as of Mar 2026Cardinal Point Capital Management ULC holds 15 biotech & pharma companies tracked by BioSniper, totaling $52.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$52.3M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 74,043 | $18.1M |
| PMPhilip Morris International Inc | 73,201 | $12.1M |
| PFEPFIZER INC | 329,107 | $9.2M |
| VTRSViatris Inc | 328,681 | $4.4M |
| ABBVAbbVie Inc. | 7,958 | $1.7M |
| GILDGILEAD SCIENCES, INC. | 10,048 | $1.4M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 4,991 | $1.4M |
| LLYELI LILLY & Co | 941 | $865K |
| MRKMerck & Co., Inc. | 6,290 | $757K |
| MCKMcKesson Corporation | 763 | $661K |
| BMYBRISTOL MYERS SQUIBB CO | 10,763 | $653K |
| ABTABBOTT LABORATORIES | 4,002 | $411K |
| BAXBaxter International Inc. | 14,250 | $239K |
| AZNASTRAZENECA PLC | 1,210 | $239K |
| VMDViemed Healthcare Inc. | 12,480 | $115K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.